Tilray Brands has added a new format to its Canadian portfolio with the launch of ZONNA, a line of THC pouches built for consumers who want an oral, smoke-free option. The debut product, Bubble Pink, uses what the company calls Capsoil technology inside a pouch meant to sit between gum and lip, positioning the brand alongside nicotine pouches in terms of form factor if not function. It's a notable move for a multinational operator that already spans flower, edibles, beverages, and vape, and it signals where product development in the adult-use category is headed next.
For retailers, a new format like this isn't just another SKU to stock - it's a fresh set of operational questions. Where does a THC pouch sit on the shelf relative to edibles or tinctures? How does budtender training need to shift to explain a 10 mg dose delivered through oral mucosa rather than digestion? Multi-location operators tracking inventory across POS terminals will need to code these pouches correctly for seed-to-sale reporting, and that's true whether a store is running provincial systems in Canada or, for U.S.-facing software vendors watching the category, platforms like the POS software for Rhode Island cannabis retailers that manage compliance logs across a very different regulatory map. Format innovation tends to outpace back-office readiness, and pouches are a good test case for that gap. POS software for Rhode Island cannabis retailers
Dosage, Packaging, and the Compliance Layer
Each ZONNA pouch is dosed at 10 mg THC, sold in containers of 15 pouches for a total of 150 mg per pack. That per-unit control matters in a category where inconsistent dosing has long been a friction point for new consumers and a liability concern for retailers fielding complaints. The child-resistant puck, with separate compartments for used and unused pouches, addresses a real packaging challenge: oral nicotine pouches have faced criticism for how discreetly they can be discarded, and cannabis regulators have generally required disposal solutions that reduce accidental exposure risk. Retailers should expect to see similar packaging logic tested across other pouch entrants as the format matures.
None of this changes the basic compliance obligations that come with any new cannabis product. Batches still require lab testing and a certificate of analysis before reaching retail shelves; age verification at the point of sale remains non-negotiable regardless of format; and marketing has to stay within the promotional limits set under the Cannabis Act, which restricts appeal to minors and prohibits health claims. A pouch may feel closer to a consumer packaged good than a traditional cannabis product, but the regulatory scaffolding underneath it is exactly the same.
What This Means for Retail Strategy
The bigger question for store operators is category placement and staff education, not just supply. Discreet, smoke-free formats tend to draw a different customer than flower or vape - often someone newer to cannabis or looking for a low-key option for daytime use. That shift in customer intent means point-of-sale conversations need to change too, with an emphasis on dose transparency and onset time rather than potency alone. Wholesale buyers evaluating shelf space will want to weigh pouch margins against edibles and beverages, categories that have already established consumer habits in most Canadian markets.
Tilray's move also reflects a broader pattern across the legal cannabis industry: producers are borrowing packaging and delivery concepts from adjacent consumer categories, including nicotine and functional wellness products, to differentiate crowded shelves. Whether that translates into durable demand - as opposed to a short-term novelty spike - is the kind of thing dispensary buyers and licensed producers alike will be watching closely over the next several purchasing cycles.